Cannabis decriminalization in Texas would be good for Village Farms, says Paradigm Capital

Moves to decriminalize marijuana in the state of Texas are good news for cannabis companies Village Farms International (Village Farms International Stock Quote, Chart TSX:VFF) and Cansortium Holdings, says Paradigm Capital analyst Rahul Sarugaser.

On Monday, a committee in the Texas House of Representatives approved a bill that would decriminalize the possession of small amounts of cannabis, replacing penalties with possession of under one ounce with a maximum US$250 fine for the first two offences. It marks the third time that a decriminalization bill written by Rep. Joe Moody has made it past the House’s Criminal Jurisprudence Committee but it’s also the quickest of the three tries, potentially boding well for its chances of success.

The Texas legislature is also considering the expansion of its medical cannabis program, which is currently restricted only to Texans with epilepsy and the only legal products these patients have available are high CBD, low THC oils.

Sarugaser says the move would expand the Texas market for three cannabis companies that won the first licenses and are currently operating in the state, namely, Cansortium Holdings and two private firms, Surterra Wellness and Compassionate Cultivation.

As well, Village Farms, with a 5.7 million square foot vegetable greenhouse facility in Texas (which it is preparing to convert for the purposes of hemp production), VFF is “particularly well-situated” to take advantage of a new law in the state, says Sarugaser.

“We recall that Village Farms was able to rapidly convert 1.1 million of its total 4.8 million square feet of its tomato greenhouses in Delta, British Columbia, for the purposes of growing cannabis during 2018, quickly making them one of the lowest cost producers of Canadian cannabis,” says Sarugaser in a client update on Wednesday.

“Evolution of the regulatory landscape in Texas bodes well for TIUM and VFF, and we expect to see strength in both of these stocks today and in the weeks to come,” he says.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: vff
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Is Peloton Stock a Buy? (May, 2024)

Following news of a restructuring, Roth MKM analyst George Kelly has chopped his price target on Peloton (Peloton Stock Quote,… [Read More]

2 days ago

Is Ascend Wellness stock a buy?

Ahead of the company's first quarter results, Beacon analyst Russell Stanley thinks Ascend Wellness (Ascend Wellness Stock Quote, Chart, News,… [Read More]

2 days ago

Paradigm chops price target on Snipp Interactive

Following the company's fourth quarter results, Paradigm Capital analyst Daniel Rosenberg has cut his price target on Snipp Interactive (Snipp… [Read More]

2 days ago

It’s time to buy cannabis stocks, this analyst says

A major development came down the pipe this week at the U.S. Drug Enforcement Agency has reportedly decided to reschedule… [Read More]

2 days ago

Is Generac stock a buy?

Following the company's first quarter results, Roth MKM analyst Chip Moore remains neutral on Generac Holdings (Generac Holdings Stock Quote,… [Read More]

3 days ago

Bombardier is a buy, Desjardins says (May, 2024)

The stock has climbed slowly but surely since last October. But is there still money to be made on Bombardier?… [Read More]

3 days ago